A Study of TQB2450 Injection Combined With Stereotactic Body Radiation Therapy (SBRT) in Subjects With Advanced Oligometastatic Non-Small Cell Lung Cancer

NCT04306926 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

59

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Oligometastatic Non-small Cell Lung Cancer

Interventions

DRUG: TQB2450
RADIATION: SBRT

Sponsor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.